Title:

EntreMed, Inc. at BIO CEO & Investor Conference Transcript

Price:$54.00
Publication Date:Feb 12, 2008
Source:Thomson StreetEvents
Report Type:Transcript
Abstract:Final Transcript of ENMD presentation, 12-Feb-08 2:45pm ET
Brief Excerpt:... - BIO Good afternoon. I'm [Michael Lesso] with BIO. Next presentation, EntreMed is a clinical stage pharmaceutical company focused on developing multi-mechanism drugs that target disease cells directly and -- in the blood vessels that nourish them. James S. Burns, EntreMed's President and CEO, will be the presenter. The breakout remains in this room within the ## minute time period. ...
Word Count:5852
Length:8 Pages
Ticker:ENMD
Time:2:45pm ET
Related Report(s):
Format:Adobe Acrobat Adobe Acrobat
Free Sample: Click Here to Download

Enter the keyword(s) which you would like to search for within this document and click "Search"

 
Purchase Report
Price: $54.00




Thomson StreetEvents

Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool. <br/>Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

  about us contact us public company index private company index pcan widget your privacy rights terms & conditions